Abstract
The Editor-in-Chief has retracted this article. After publication, the corresponding author stated that he has been unable to reproduce the targeting relationship between miR- 34a and MYCN in animal experiments. Additionally, the authors have been unable to provide documents confirming that ethics approval was obtained for this study. The Editorin- Chief therefore considers the data reported in this the article to be unreliable.The authors have not responded to correspondence regarding this retraction notice.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 1207 |
| Number of pages | 1 |
| Journal | Cellular Oncology |
| Volume | 44 |
| Issue number | 5 |
| DOIs |
|
| State | Published - Oct 2021 |
Bibliographical note
Publisher Copyright:© International Society for Cellular Oncology 2019
Fingerprint
Dive into the research topics of 'Retraction Note: Human bone marrow-derived mesenchymal stem cell-secreted exosomes overexpressing microRNA-34a ameliorate glioblastoma development via down-regulating MYCN (Cellular Oncology, (2019), 42, 6, (783-799), 10.1007/s13402-019-00461-z)'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS